(Q38443104)

3 September 2017

1 reference

title

Oral anticoagulants and risk of nephropathy (English)

1 reference

3 September 2017

1 reference

Vinay Narasimha Krishna

1

1 reference

3 September 2017

David G Warnock

2

1 reference

3 September 2017

Nakshatra Saxena

3

1 reference

3 September 2017

Dana V Rizk

4

1 reference

3 September 2017

publication date

1 June 2015

1 reference

3 September 2017

1 reference

3 September 2017

volume

38

1 reference

3 September 2017

issue

6

1 reference

3 September 2017

page(s)

527-533

1 reference

https://scigraph.springernature.com/pub.10.1007/s40264-015-0290-z

3 September 2017

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Warfarin dosing in patients with impaired kidney function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Frequency of adverse events in patients with poor anticoagulation: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

A clinician's perspective: novel oral anticoagulants to reduce the risk of stroke in nonvalvular atrial fibrillation--full speed ahead or proceed with caution?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

A meta-analysis of phase III randomized controlled trials with novel oral anticoagulants in atrial fibrillation: comparisons between direct thrombin inhibitors vs. factor Xa inhibitors and different dosing regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Clinical experience with the new oral anticoagulants for treatment of venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

New oral anticoagulants: a review of the literature with particular emphasis on patients with impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Oral warfarin and the thrombin inhibitor dabigatran increase blood pressure in rats: hidden danger of anticoagulants?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

The occurrence of warfarin-related nephropathy and effects on renal and patient outcomes in korean patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Haematuria and acute kidney injury in elderly patients admitted to hospital with supratherapeutic warfarin anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

An unusual cause of gross hematuria and transient ARF in an SLE patient with warfarin coagulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Anticoagulants and acute kidney injury: clinical and pathology considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Kidney function influences warfarin responsiveness and hemorrhagic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Role of caspases on cell death, inflammation, and cell cycle in glycerol-induced acute renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Physiology and pathophysiology of heme: implications for kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

N-acetylcysteine ameliorates acute kidney injury but not glomerular hemorrhage in an animal model of warfarin-related nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Warfarin slows deterioration of renal function in elderly patients with chronic kidney disease and atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Gas6, warfarin, and kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Warfarin-induced allergic interstitial nephritis and leucocytoclastic vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Warfarin-induced leukocytoclastic vasculitis: a case report and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Cholesterol emboli associated with warfarin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Warfarin-induced bilateral renal hematoma causing acute renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Implications of new anticoagulants in primary practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Patient with acute renal injury presenting dabigatran overdose: Hemodialysis for surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

New avenues for anticoagulation in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Protease-activated receptors in hemostasis, thrombosis and vascular biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Endothelial cytoskeletal reorganization in response to PAR1 stimulation is mediated by membrane rafts but not caveolae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Warfarin therapy and systolic hypertension in men with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40264-015-0290-Z

Redox cycling of human methaemoglobin by H2O2 yields persistent ferryl iron and protein based radicals

21 January 2018

1 reference

12 December 2020

[Prospective study of drug-induced interstitial nephritis in eleven French nephrology units]

1 reference

12 December 2020

Fatal dabigatran toxicity secondary to acute renal failure

1 reference

12 December 2020

Protease-activated receptors in vascular biology

1 reference

12 December 2020

Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study

1 reference

12 December 2020

Acute renal failure caused by severe coagulopathy induced by the interaction between warfarin potassium and levofloxacin: a case report

1 reference

12 December 2020

A case of dabigatran-associated acute renal failure.

1 reference

12 December 2020

Dabigatran overdose secondary to acute kidney injury and amiodarone use.

1 reference

12 December 2020

An unusual cause of glomerular hematuria and acute kidney injury in a chronic kidney disease patient during warfarin therapy.

1 reference

12 December 2020

Direct oral anticoagulants--pharmacology, drug interactions, and side effects

1 reference

12 December 2020

Thin basement membrane disease and acute renal failure secondary to gross hematuria and tubular necrosis

1 reference

12 December 2020

Apixaban Use Among Patients With Severe Renal Impairment

1 reference

12 December 2020

Ciprofloxacin-warfarin coagulopathy: a case series

1 reference

12 December 2020

10.1007/S40264-015-0290-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

1010314346

0 references

1 reference